Somatic mutations in TSC1 and TSC2 also contribute to tumor growth via unopposed mTOR signaling, and sporadic AML is similarly characterized by somatic loss-of-function alterations in TSC2 [9]. This evidence concerns the gene MTOR and acute myeloid leukemia.